LORENA CASTILLO: Open Payments
NPI 1194116616 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 26 payments from 10 companies in 2025. Trend: 2023 $799 · 2024 $169 · 2025 $447
Food & beverage: $386Education: $61
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $183 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| ARRAY BIOPHARMA INC | 8 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| BeOne Medicines USA, Inc. | 1 | $34 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Incyte Corporation | 1 | $20 |
| Myriad Genetic Laboratories, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
Products named: BRAFTOVI, IBRANCE, TUKYSA, PADCEV, FRUZAQLA, BRUKINSA, PLUVICTO, XTANDI.
Industry payments across GA — which companies pay providers there.
